BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10879100)

  • 1. [Pax-5 genes and CD19 molecules in human myeloma].
    Ishikawa H; Kawano M
    Rinsho Ketsueki; 2000 May; 41(5):404-7. PubMed ID: 10879100
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered expression of Pax-5 gene in human myeloma cells.
    Mahmoud MS; Huang N; Nobuyoshi M; Lisukov IA; Tanaka H; Kawano MM
    Blood; 1996 May; 87(10):4311-5. PubMed ID: 8639790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
    Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
    EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.
    Meffre E; LeDeist F; de Saint-Basile G; Deville A; Fougereau M; Fischer A; Schiff C
    J Clin Invest; 1996 Oct; 98(7):1519-26. PubMed ID: 8833898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanism of oncogenesis and progression in human myeloma].
    Kawano MM; Otsuyama K
    Nihon Rinsho; 2007 Dec; 65(12):2187-93. PubMed ID: 18069259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX: developmental control genes in cell growth and differentiation.
    Stuart ET; Gruss P
    Cell Growth Differ; 1996 Mar; 7(3):405-12. PubMed ID: 8838870
    [No Abstract]   [Full Text] [Related]  

  • 7. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
    Jiang H; Gao W; Sze DM; Xiong H; Hou J
    Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in DNA binding activity of the transcription factor Pax-5a in B lymphocytes of aged mice.
    Anspach J; Poulsen G; Kaattari I; Pollock R; Zwollo P
    J Immunol; 2001 Feb; 166(4):2617-26. PubMed ID: 11160324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of BSAP (Pax-5) in B-cell development.
    Busslinger M; Urbánek P
    Curr Opin Genet Dev; 1995 Oct; 5(5):595-601. PubMed ID: 8664547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential functions of Pax-5 (BSAP) in pro-B cell development.
    Nutt SL; Thévenin C; Busslinger M
    Immunobiology; 1997 Dec; 198(1-3):227-35. PubMed ID: 9442394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1/Egr-1 binding site and a novel site termed the PyG box.
    Riva A; Wilson GL; Kehrl JH
    J Immunol; 1997 Aug; 159(3):1284-92. PubMed ID: 9233624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.
    Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M
    Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis.
    Rhoades KL; Singh N; Simon I; Glidden B; Cedar H; Chess A
    Curr Biol; 2000 Jun; 10(13):789-92. PubMed ID: 10898982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoallelic expression of Pax5: a paradigm for the haploinsufficiency of mammalian Pax genes?
    Nutt SL; Busslinger M
    Biol Chem; 1999 Jun; 380(6):601-11. PubMed ID: 10430025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dependence of BSAP repressor and activator functions on BSAP concentration.
    Wallin JJ; Gackstetter ER; Koshland ME
    Science; 1998 Mar; 279(5358):1961-4. PubMed ID: 9506950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent regulation of the two Pax5 alleles during B-cell development.
    Nutt SL; Vambrie S; Steinlein P; Kozmik Z; Rolink A; Weith A; Busslinger M
    Nat Genet; 1999 Apr; 21(4):390-5. PubMed ID: 10192389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax genes and their roles in cell differentiation and development.
    Mansouri A; Hallonet M; Gruss P
    Curr Opin Cell Biol; 1996 Dec; 8(6):851-7. PubMed ID: 8939674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes.
    Masten SA; Shiverick KT
    Biochem Biophys Res Commun; 1995 Jul; 212(1):27-34. PubMed ID: 7541987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.